Pediatric Clinical Practice Guidelines for Nurses in Primary Car

Subject Index

A  B  C  D   E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y   Z 

Note: "URTI" stands for upper respiratory tract infection

A

ABCs (airway, breathing, circulation)

in acute seizures, 15-5
in burns, major, 16-19
in epiglottitis, 10-17
in head trauma, 15-9
in neonatal resuscitation, 10-18, 10-19
in trauma situations, 20-2, 20-3, 20-4

Abdominal examination

newborns, 1-5
in trauma situations, 20-5

Abdominal pain, and

acetaminophen overdose, 20-13
acute abdomen, 12-11 to 12-12
appendicitis, 12-13
assessment, general, 12-1 to 12-2
bowel obstruction, 12-14
constipation, 12-7
erythema infectiosum, 18-10
glomerulonephritis, 13-7
incarcerated hernia, 12-5
milk protein sensitivity, 17-10
pharyngotonsillitis, 9-8
pinworms, 18-18
scarlet fever, 18-6
urinary tract infection, 13-3

Abortion counseling, 19-4

Abscesses

brain, and headaches, 15-10
retropharyngeal, peritonsillar, 9-11 to 9-12

Abuse. See Alcohol abuse; Child abuse; Substance abuse

Accidents. See Injuries

Acetaminophen, overdoses and antidotes, 20-13 to 20-14

Acetaminophen, uses

acute otitis media, 9-4
burns, minor, 16-19
cellulitis, 16-7, 16-8
croup, 10-5
erythema infectiosum, 18-11
German measles, 18-9
growing pains (musculoskeletal), 14-8
headaches, tension and mild migraines, 15-13
limb pain, 14-4
limping, 14-7
measles (rubeola), 18-6
meningitis, 18-21
mumps, 18-16

Acetaminophen, uses (continued)

Osgood-Schlatter disease, 14-8
pharyngotonsillitis, 9-9, 9-10
roseola infantum, 18-12
scarlet fever, 18-7
stomatitis, 9-8
URTI, 10-3

Acetylsalicylic acid. See ASA (acetylsalicylic acid)

Acid-reducing agents, for GERD, 12-10

Acne, 16-14 to 16-15

Acquired immunodeficiency syndrome (AIDS), 18-2

Acromegaly, weight/height correlation, 3-5

Activated charcoal, antidote for poisoning, 20-14

Acute angle-closure glaucoma. See Adult Clinical Guidelines

Acute otitis media. See Otitis media, acute

ADHD (attention deficit hyperactivity disorder), 6-4 to 6-5

Adolescent health, 19-1 to 19-7

causes of death, 19-1
contraception and, 19-5
developmental stages, 19-1
examination, physical, 1-1, 19-2 to 19-3
history taking, 1-2, 19-2
pregnancy (see Pregnancy)
psychosocial evaluation, 19-2
puberty, 19-3
sexuality (see Sexuality)
suicide (see Adult Clinical Guidelines)
Tanner staging, 19-3

AIDS (acquired immunodeficiency syndrome), 18-2

Airway

injury, in trauma, 20-1
obstruction, in acute asthma, 10-12
obstruction, in epiglottitis, 10-16
oral airway, in trauma situation, 20-3
primary survey in trauma, 20-2

Alcohol, and breast milk toxicology, 7-6

Alcohol abuse

guidance about intake, 3-3
maternal intake, and fetus health, 6-2, 6-3
prevention/treatment, 19-6, 19-7
risk factors, 19-6

Alcohol-related birth defects (ARBD). See Fetal alcohol syndrome/effects

Alcohol-related neurologic disorders (ARND). See Fetal alcohol syndrome/effects

Allergic conjunctivitis. See Adult Clinical Guidelines

C--2 Index

Allergies, 17-8 to 17-12

in general, 17-8
hives (urticaria), 17-9 to 17-10
lactose intolerance, 17-11 to 17-12
milk protein sensitivity, 17-10

Aluminum acetate compresses, for eczema, 16-9

Aluminum-magnesium-simethicone suspension, for GERD, 12-10

Amnesia, in head trauma, 15-7

Amoxicillin, uses

acute otitis media, 9-4, 9-5
cystitis, 13-4
pneumonia, 10-10
prepubescent vaginal discharge, 13-7

Amphetamine abuse, 19-6 to 19-7

Ampicillin, uses

appendicitis, 12-14
bacteremia or sepsis, 20-18
and breast milk toxicology, 7-6
epiglottitis, 10-17
meningitis, 18-21
pneumonia, 10-10
pyelonephritis, 13-4
sepsis in newborns, 10-20

Anaphylaxis, 20-7 to 20-9

bronchospasm, 20-9
causes, 20-7
definition, 20-7
diphenhydramine dosage, 20-9
epinephrine dosage, 20-8, 20-9
history and phys ical findings, 20-7 to 20-8
pharmacologic interventions, 20-8 to 20-9

Anemia, 17-1 to 17-2

differential diagnosis, 17-2
GERD and, 12-9
history and physical, 17-1
normal hemoglobin levels, 17-1
risk factors, 3-6
screening for, 3-6

Anesthesia, local, for suturing, 2-4

Ankyloglossia (tongue-tie), 9-15

Anodontia (congenital absence of teeth), 9-16

Anorexia, and

appendicitis, 12-13
bronchiolitis, 10-6
glomerulonephritis, 13-7
headaches, 15-11
mumps, 18-15
pneumonia, 10-9
rickets, 7-11

Antibiotics, uses

appendicitis, 12-14
bacteremia or sepsis, 20-18
bacterial pharyngotonsillitis, 9-9
botulism, 18-4
burns, minor, 16-19
Antibiotics, uses (continued)
cellulitis, 16-7, 16-8
conjunctivitis, 8-5
diphtheria, 18-15
epiglottitis, 10-17
fractures, 14-13
impetigo, 16-6
orbital cellulitis, 8-10
periorbital cellulitis, 8-11, 16-6
pneumonia, 10-10
prophylaxis for acute otitis media, 9-5
retropharyngeal/peritonsillar abscesses, 9-12
scarlet fever, 18-7
sepsis in newborns, 10-20

Anticonvulsants, for chronic seizure disorders, 15-6

Antihistamines, contraindications, 9-4, 9-6, 10-3

Antitoxins, for botulism, 18-4

Antiviral agents, for bronchiolitis, 10-8

Apgar score, 1-7, 10-18

Aphthous stomatitis, 9-7 to 9-8

Apnea, and

GERD, 12-9
pertussis (whooping cough), 18-16, 18-17

Appendicitis, 12-13 to 12-14

Arthritis

with German measles, 18-8
migratory, in rheumatic fever, 11-5

ASA (acetylsalicylic acid)

and breast milk toxicology, 7-6
contraindications (Reye's syndrome), 15-13

Asphyxia, perinatal, 10-17 to 10-19

Aspiration of meconium, 10-20

Assessment

history taking, 1-2
newborns, physical examination, 1-3 to 1-8, 14-6
physical examination, 1-2
well-child assessment, components, 1-1
See also Developmental progress; Growth

problems

Asthma, acute, 10-11 to 10-13

history and physical, 10-11
causes, 10-11
airway obstruction, severe, 10-12
differential diagnosis, 10-12
exacerbation, severity of, 10-11 to 10-12
management, 10-12 to 10-13
risk factors, 10-12
"silent chest," 10-12

Asthma, chronic, 10-13 to 10-15

and bronchiolitis, 10-7
management, 10-13 to 10-15
types defined, 10-13

Atopic dermatitis (eczema), 16-8 to 16-9

Atropine, antidote for poisoning, 20-14

Attention deficit hyperactivity disorder (ADHD), 6-4 to 6-5

Audiometry, pure-tone, 3-6, 3-10

Auscultation

abdomen, gastrointestinal problems, 12-1
abdomen, in pediatric trauma, 20-5
abdomen, newborns, 1-5
with cardiovascular problems, 11-2
cardiovascular system, newborns, 1-5
chest, in pediatric trauma, 20-2, 20-5
examination for communicable diseases, 18-1
for heart murmurs, 11-3
respiratory problems, 10-2
respiratory system, newborns, 1-5

Aveeno baths, for chickenpox, 18-13

AVPU method of neurologic evaluation, 20-2

Avulsion fractures. See Fractures

B

Bacitracin ointment, for minor burns, 16-19

Bacteremia, occult, 20-15 to 20-18

causes, 20-15
diagnosis, 20-17
history and physical, 20-16
management, 20-17 to 20-18
risk factors, 20-15

Balanitis. See Adult Clinical Guidelines

"Barrel chest" and respiratory problems, 10-2, 10-5

Battle's sign, in pediatric trauma, 20-3, 20-4

BCG vaccine (against tuberculosis), 18-19

β₂-agonists. See Bronchodilators

Betamethasone, for hereditary polymorphic light eruption, 16-11

Birth control, 19-5

Blackheads (in acne), 16-14 to 16-15

Blood glucose levels, in diabetes mellitus, 17-6

Blood loss, in trauma situations, 20-2

Blood pressure

with acute seizures, 15-5
with dehydration, 4-2
with head trauma, 15-8
in newborns, 1-3
"normal," 20-1
vital sign in cardiovascular problems, 11-2

Blurring of vision. See Visual disturbances

Botulism, 18-2 to 18-4

differential diagnosis, 18-3
forms of, 18-2
history and physical, 18-3
management, 18-3 to 18-4
transmission and contagion, 18-2

Bowel obstruction, 12-14 to 12-15

causes and management, 12-14 to 12-15
and dehydration, 4-1
in newborns, 10-21, 12-14

Bradycardia, and

head trauma, 15-8
meningitis, 18-21
shock, 20-10

Brain lymphoma, and AIDS, 18-2

Breast-feeding, 7-1 to 7-5

advantages, 7-1
breast care, 7-4
breast milk toxicology, 7-6
complications, 7-4 to 7-5
lactation problems, 7-5
techniques, 7-2 to 7-3
vitamin supplements, 7-4, 7-7, 7-11

Breath sounds, in

bronchiolitis, 10-6
newborn examination, 1-5
pneumonia, 10-9
respiratory distress, 10-5
respiratory examination, 10-2
severe airway obstruction, 10-12

Bronchiolitis, 10-6 to 10-8

differential diagnosis, 10-7
history and physical, 10-6
management, 10-7 to 10-8
mild, 10-7
moderate to severe, 10-8

Bronchodilators (β₂-agonists), uses

asthma, acute, 10-13
asthma, chronic, 10-14
bronchiolitis, 10-7, 10-8

Bronchospasms, in anaphylaxis, 20-9

Brudzinski's sign, and meningitis, 18-21, 20-16

Bruising

with dislocation of major joint, 14-13
estimating age of bruises, 5-2
examination of skin, 16-2
possible abuse situation, 5-2

Budesonide, for chronic asthma, 10-14

Bullae (skin lesions), 16-2

Burns, 16-15 to 16-20

causes, 16-16
chemical, to eyes (see Adult Clinical Guidelines)
degrees of, 16-15
and dehydration, 4-1
depth assessment, 16-16
extent of, 16-17
first aid measures, 16-18
injury pattern, classification by, 16-17
intentional (child abuse), 16-16
major burns, treatment, 16-19 to 16-20
minor/less severe burns, treatment, 16-18 to 16-19
severity, classification, 16-17

C

Café au lait spots, in newborns, 1-3

Caffeine, and breast milk toxicology, 7-6

Calamine lotion, for chickenpox, 18-13

Calcium deficiency, and rickets, 7-10

Calcium supplements, for lactose intolerance, 17-12

Canadian Task Force on Preventive Health Care, screening recommendations, 3-6 to 3-7

Candida

and diaper rash, 16-9
and meningitis, 18-20
and prepubescent vaginal discharge, 13-6

Car seats, 3-2 to 3-3

Carbamate insecticide poisoning, 20-14

Carbamazepine

and breast milk toxicology, 7-6
for seizure disorders, 15-6

Carbohydrates, nutritional value, 7-1

Cardiac failure, 11-7 to 11-8

Cardiovascular problems, 11-1 to 11-8

history, general, 11-1
examination, general, 11-2
in adolescents, 19-2
cardiac failure, 11-7 to 11-8
congestive heart failure with glomerulonephritis, 13-7
cyanosis in newborns, 11-4 to 11-5
with diabetes mellitus, 17-7
heart murmurs, 11-3 to 11-4
rheumatic fever, 11-5 to 11-7
See also Heart

Cardiovascular system

evaluation in trauma situations, 20-5
examination in newborns, 1-5
See also Cardiovascular problems; Heart

Carditis (rheumatic fever), 11-5 to 11-7

Catheterization (Foley), 20-3

Catheters, in intravenous access, 2-2

Cefaclor, for acute otitis media, 9-4

Cefazolin, for limb pain, 14-4

Ceftriaxone, uses

bacteremia or sepsis, 20-18
fractures, 14-13
meningitis, 18-21

Cefuroxime, uses

cellulitis, 16-8
epiglottitis, 10-17
fractures, 14-13
limb pain, 14-4
pneumonia, 10-10

Cellulitis, 16-6 to 16-8

clinical history, 16-6 to 16-7
differential diagnosis, 16-7
mild, management, 16-7
moderate to severe, management, 16-7 to 16-8
orbital, 8-10, 16-6
periorbital, 8-7, 16-6

Central nervous system problems, 15-1 to 15-13

history, general, 15-1
examination, general, 15-1
examination, newborns, 1-6 to 1-7
with fetal alcohol syndrome, 6-2
Glasgow coma scale, 15-2, 15-8, 20-6
head trauma, 15-7 to 15-9
headaches, 15-9 to 15-13
headaches, charting, 15-14 to 15-15
hypotonia ("floppy infant"), 15-3, 18-3
from inhalant abuse, 19-7
lesions of, and constipation, 12-7
neurologic examination in trauma situations, 20-2, 20-6
seizure disorders, 15-4 to 15-7

Cephalexin, and breast milk toxicology, 7-6

Cerebral palsy

and constipation, 12-7
vs. learning disabilities, 6-1

Cervical collar, in trauma situations, 20-4

Chalazion. See Adult Clinical Guidelines

Charcoal, antidote for poisoning, 20-13, 20-14

Chemical burns (eyes). See Adult Clinical Guidelines

Chest trauma, in children, 20-1

Chickenpox (varicella), 18-12 to 18-13

Child abuse, 5-1 to 5-3

consideration in joint dislocations, 14-13
differential diagnosis, 5-2
head trauma, 15-7
indicators, 5-2
intentional burns, 16-16
legal aspects, 5-3, 13-6
management, 5-3
situations, 5-1
types, 5-1
See also Sexual abuse

Chin, inspection in newborns, 1-4

Chlamydia

and neonatal conjunctivitis, 8-6
reportable cases, 13-7

Chloramphenicol, for epiglottitis, 10-17

Chlorpromazine, and breast milk toxicology, 7-6

Choanal atresia (in newborns), 1-4

Choking precautions, 3-2 to 3-3

Chronic otitis media, 9-5

See also Adult Clinical Guidelines

Cimetidine, for GERD, 12-10

Circulation, in neonatal resuscitation, 10-19, 10-20

Clindamycin phosphate, for appendicitis, 12-14

Closed fractures. See Fractures

Cloxacillin, uses

cellulitis, 16-7, 16-8
impetigo, 16-6

Clubbing, and

cardiovascular problems, 11-2
respiratory problems, 10-2

Cocaine, abuse, 19-6 to 19-7

Codeine, uses

and breast milk toxicology, 7-6
dislocations, 14-14
fractures, 14-13

Comedones, in acne, 16-14

Comminuted fractures . See Fractures

Communicable diseases, 18-1 to 18-22

history and physical findings, 18-1
botulism, 18-2 to 18-4
chickenpox (varicella), 18-12 to 18-13
diphtheria, 18-13 to 18-15
erythema infectiosum (fifth disease), 18-10 to 18-11
exanthems (rash), 18-4 to 18-12
hepatitis, 18-19 (see also Adult Clinical Guidelines)
meningitis, 18-20 to 18-22
mononucleosis (see Adult Clinical Guidelines)
parotitis (mumps), 18-15 to 18-16
pertussis (whooping cough), 18-16 to 18-17
pinworms, 18-18
roseola infantum, 18-11 to 18-12
rubella (German measles), 18-8 to 18-9
rubeola (measles), 18-5 to 18-6
scarlet fever, 18-6 to 18-8
tuberculosis, 18-19 (see also Adult Clinical Guidelines)

Condoms, 19-5

Congenital dislocation of hip (hip dysplasia), 14-5 to 14-6

Congenital heart disease, and newborn cyanosis, 11-4

Congestive heart failure, and glomerulonephritis, 13-7

Conjunctivitis, 8-4 to 8-5

allergic conjunctivitis (see Adult Clinical Guidelines)
as cause of red eye, 8-2
causes, 8-4
differential diagnosis, 8-4
with German measles, 18-8
management, 8-5

Consciousness, level of

with acute seizures, 15-5
with anaphylaxis, 20-8
and central nervous system problems, 15-1
in dehydration, 4-2
Glasgow coma scale, 15-2, 15-8, 20-6
in head trauma, 15-7, 15-8
with meningitis, 18-20
shock, 20-10
in trauma situations, 20-2, 20-6

Constipation, 12-6 to 12-8

and botulism, 18-3
causes, 12-6 to 12-7
history and physical, 12-7
management, 12-7 to 12-8

Contraception, 19-5

Corneal abrasions. See Adult Clinical Guidelines

Corneal light reflex test, 3-7, 3-11, 8-9

Corticosteroids, uses

chronic asthma, 10-14
croup, 10-6

Coryza, and

erythema infectiosum, 18-10
rubeola (measles), 18-5

Cough suppressants, 10-3, 10-16

Coughs, and

anaphylaxis, 20-7
asthma, 10-11
bronchiolitis, 10-6
croup, 10-4
diphtheria, 18-14
GERD, 12-9
likely illness, 10-1
persistent, 10-15 to 10-16
pneumonia, 10-9
rheumatic fever, 11-5
rubeola (measles), 18-5
URTI, 10-3
whooping cough (pertussis), 18-16 to 18-17

Counseling

adolescents re sexuality, 3-3, 19-4, 19-5
parents or caregivers, 3-8
pregnant adolescents, 19-4
re abortion, 19-4

Crackles, and

bronchiolitis, 10-6
heart failure, 11-2, 11-7
pneumonia, 10-9
respiratory problems, 10-2

Cranial injuries. See Head trauma

Criminal Code of Canada, on child abuse, 5-3

Croup, 10-4 to 10-6

clinical his tory, 10-4 to 10-5
differential diagnosis, 10-5
management, 10-5 to 10-6
mild, 10-5
moderate to severe, 10-6
vs. epiglottitis, 10-16

Cryptococcus infection, and AIDS, 18-2

Cryptosporidiosis, and AIDS, 18-2

Cushing response, to head trauma, 15-8

Cushing's disease, weight/height correlation, 3-5

Cyanosis, and

acute asthma, 10-12
acute seizures, 15-5
cardiac, in newborns, 1-5, 11-4 to 11-5

Cyanosis, and

cardiac failure, 11-7
cardiovascular problems, 11-1, 11-2
epiglottitis, 10-16
GERD, 12-9
pertussis (whooping cough), 18-16, 18-17
respiratory problems, 10-1, 10-5

Cystitis, 13-3 to 13-4

Cysts

in acne, 16-14
eruption cysts in infants, 9-14

D

Dacryostenosis (nasolacrimal duct obstruction), 8-7

DDST (Denver Developmental Screening Test), 3-6, 3-9

Decongestants, uses

contraindicated for otitis media, 9-4, 9-6
URTI, 10-3

Deferoxamine, for iron poisoning, 20-14, 20-15

Dehydration, 4-1 to 4-3

clinical features, 4-2
in gastroenteritis, 12-4, 12-5
and gastrointestinal obstruction, 4-1
management, 4-2 to 4-3, 12-4

Dental problems. See Mouth and throat conditions

Denver Developmental Screening Test (DDST),

3-6, 3-9

Depression

in abuse situations, 5-2
vs. learning disabilities, 6-1

Dermatitis

atopic (eczema), 16-8 to 16-9
poison ivy, 16-10 to 16-11

Developmental progress

growth measurements, newborns, 1-3, 17-3
growth measurements, well-child care, 3-4
hypotonia ("floppy infant"), 15-3
milestones for first 2 years, 1-3
screening, 3-6, 3-9
See also Assessment; Growth problems

Dexamethasone, for croup, 10-6

Diabetes mellitus, 17-5 to 17-8

in adolescent pregnancy, 17-8
complications, 17-7
and constipation, 12-6
and dehydration, 4-1
diagnostic tests (blood glucose levels, urinalysis), 17-6
history and physical findings, 17-6
management, 17-7 to 1 7-8
types 1 and 2, 17-5
Diaper rash, 16-9 to 16-10

Diarrhea, and

acute otitis media, 9-3
AIDS, 18-2
botulism, 18-3
bowel obstruction, 12-14
dehydration, 4-1
gastroenteritis, 12-3
intussusception, 12-16
iron poisoning, 20-14
lactose intolerance, 17-11
milk protein sensitivity, 17-10
roseola infantum, 18-11
urinary tract infection, 13-3
See also Gastroenteritis

Diazepam

and breast milk toxicology, 7-6
for seizures, 15-6

Diet. See Nutrition and diet

Digoxin

and breast milk toxicology, 7-6
for cardiac failure, 11-8

Diphenhydramine hydrochloride, uses

anaphylaxis, 20-9
chickenpox, 18-13
hives (urticaria), 17-9
poison ivy dermatitis, 16-10
pruritus, 16-5

Diphtheria, 18-13 to 18-15

and bacterial pharyngotonsillitis, 9-8
cause and transmission, 18-13 to 18-14
history and physical findings, 18-14 to 18-15
management, 18-14 to 18-15
vaccines, 18-14

Dislocation of hip, congenital (hip dysplasia), 14-5 to 14-6

Dislocations, major joints, 14-10, 14-13 to 14-14

Displaced fractures. See Fractures

Diuretics, use in head trauma, 15-9

Domperidone, for GERD, 12-10

Down's syndrome, weight/height correlation, 3-5

DPT (diphtheria-pertussis-tetanus) vaccine, 18-14, 18-17

Drowning, safety precautions, 3-2 to 3-3

Drug abuse, 19-6 to 19-7

Dysfunctional problems, 6-1 to 6-5

attention deficit hyperactivity disorder, 6-4 to 6-5
fetal alcohol syndrome/effects, 6-2 to 6-4
learning disabilities, 6-1

Dysphagia, and

abscesses, retropharyngeal/peritonsillar, 9-11
anaphylaxis, 20-8
botulism, 18-3
croup, 10-4
epiglottitis, 10-16
GERD, 12-9
mumps, 18-15
stomatitis, 9-7

Dysplasia, developmental hip (congenital dislocation of hip), 14-5 to 14-6

Dyspnea, and

asthma, 10-11, 10-12
cardiac failure, 11-7
pneumonia, 10-9
respiratory problems, general, 10-1
rheumatic fever, 11-5

Dysuria, and

prepubescent vaginal discharge, 13-6
urinary tract infection, 13-3

E

Ear, nose, and throat conditions, 9-1 to 9-17

cardinal symptoms, 9-1
general examination, 9-2
See also Ear conditions; Nasal conditions; Mouth and throat conditions

Ear conditions, 9-3 to 9-6

cardinal symptoms, 9-1
acute otitis media, 9-3 to 9-5
examination, 9-2
otitis externa (see Adult Clinical Guidelines)
serous otitis media, 9-5 to 9-6

Ears

examination, 1-4, 9-2
hearing screening, 3-6, 3-10
inspection in newborns, 1-4
See also Ear conditions

Ecstasy (drug) use, 19-6 to 19-7

Eczema (atopic dermatitis), 16-8 to 16-9

with milk protein sensitivity, 17-10
and respiratory problems, 10-2

Edema, and

anaphylaxis, 20-7, 20-8
cardiovascular problems, 11-2
cellulitis, 16-7
conjunctiva, in ophthalmia neonatorum, 8-6
glomerulonephritis, 13-7
malignant brain edema (in head trauma), 15-7
milk protein sensitivity, 17-10
periorbital, in roseola infantum, 18-12
periorbital cellulitis, 8-11
poison ivy dermatitis, 16-10
rheumatic fever, 11-5
skin problems, 16-2

Electrical shock, safety precautions, 3-2

Emergencies

anaphylaxis, 20-7 to 20-9
definitive care, 20-6 to 20-7
gastric tube, 20-3
general, 20-1 to 20-7
Glasgow coma scale, 15-2, 15-8, 20-6
overdoses, 20-11 to 20-15
poisoning, 20-11 to 20-15
primary survey, 20-2
resuscitation, 20-3
secondary survey, 20-4 to 20-6
shock, 20-3
types, 20-1
urinary catheterization, 20-3
See also Medevac emergencies

Emotional abuse. See Child abuse

Encephalopathy, and AIDS, 18-2

Endocrine problems, Cushing's disease, 3-5

Energy (kilocalories), 7-1

Engorgement, in breast-feeding, 7-4

Epiglottitis, 10-16 to 10-17

definition, 10-16
differential diagnosis, 10-16
management, 10-17
vs. croup, 10-16

Epilepsy. See Seizures

Epinephrine, uses

anaphylaxis, 20-8, 20-9
neonatal resuscitation, 10-19

Epistaxis, 9-12 to 9-14

causes, 9-12
clinical history, 9-12 to 9-13
management, 9-13 to 9-14

Epstein pearls, in newborns, 1-4, 9-14

Erythema

erythema toxicum, in newborns, 1-3
infectiosum (fifth disease), 18-10 to 18-11
with prepubescent vaginal discharge, 13-6

Erythromycin, uses

bacterial conjunctivitis, 8-5
bacterial pharyngotonsillitis, 9-9
and breast milk toxicology, 7-6
cellulitis, 16-7
diphtheria, 18-15
impetigo, 16-6
nasolacrimal duct obstruction, 8-7
pertussis (whooping cough), 18-17
pneumonia, 10-10
prophylaxis for neonatal conjunctivitis, 8-6
retropharyngeal/peritonsillar abscesses, 9-12
rheumatic fever (carditis), 11-7
scarlet fever, 18-7

Erythromycin ethylsuccinate suspension, uses

bacterial pharyngotonsillitis, 9-9
neonatal conjunctivitis (Chlamydia infection), 8-6
pneumonia, 10-10

Erythromycin-sulfisoxazol, uses

acute otitis media, 9-4
pneumonia, 10-10

Esophagitis, and GERD, 12-9

Ethanol, antidote for poisoning, 20-14

Ethylene glycol poisoning, 20-14

Exanthems (rashes), 18-4 to 18-12

Exercise, and diabetes mellitus, 17-7

Eye conditions, 8-1 to 8-12

cardinal symptoms, 8-1
acute angle-closure glaucoma (see Adult Clinical Guidelines)
allergic conjunctivitis (see Adult Clinical Guidelines)
blunt/lacerating ocular trauma (see Adult Clinical Guidelines)
chalazion (see Adult Clinical Guidelines)
chemical burns (see Adult Clinical Guidelines)
conjunctivitis, 8-4 to 8-5
corneal abrasions (see Adult Clinical Guidelines)
foreign bodies in (see Adult Clinical Guidelines)
hordeolum (stye) (see Adult Clinical Guidelines)
nasolacrimal duct obstruction (dacryostenosis), 8-7
neonatal conjunctivitis (ophthalmia neonatorum), 8-6
orbital cellulitis, 8-10, 16-6
periorbital cellulitis, 8-11, 16-6
red eye, 8-2 to 8-4
strabismus (squinting), 8-8 to 8-9
uveitis (iritis) (see Adult Clinical Guidelines)

Eyes

examination in adolescents, 19-2
history and physical examination, 8-1 to 8-2
inspection in newborns, 1-4
ocular alignment, 3-11
vision screening, 3-7, 3-11 to 3-12
See also Eye conditions